Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

BST2 protein and certain T cells increase in early alopecia areata.

Ritlecitinib is safe for treating alopecia areata for up to 48 weeks.

Vitamin D Dependent Rickets Type-2A can cause complete hair loss and bone growth issues in infants.

A new syndrome, Teelwani Syndrome, combines features of two rare genetic disorders.

A 2-year-old girl with a rare vitamin D disorder had rickets and hair loss, but treatment was ineffective due to poor compliance.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Gene therapy and new treatments offer hope for HTRA1-related disorders.

Enhancing Tregs can protect against alopecia areata.

Defective nuclear transport may cause gene expression changes in Progeria.

ALRN-6924 may prevent hair loss caused by chemotherapy.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

An 11-year-old girl with a rare skin disorder also had cornea issues and dry eye, needing careful management.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

Rothmund-Thomson syndrome type 2 can cause chronic, poorly healing wounds.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

A deletion in the CDH3 gene causes a rare disorder with short hair and vision loss.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Autoimmune reactions may cause both alopecia areata and HAM.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A 2-year-old boy was diagnosed with a rare genetic condition causing fragile hair, intellectual issues, and short stature.

SQSTM1 is linked to increased risk of alopecia areata.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.